This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

Professionals 207 Users Online

DNA and RNA Sample Preparation Market

Market Study on DNA and RNA Sample Preparations: North America to Remain Leading Regional Market

DNA and RNA Sample Preparation Market Segmented By Clinical Testing, Diagnostic Testing, Research Applications with Workstations and Kits Products

DNA and RNA Sample Preparation Market Outlook (2022-2032)

The global DNA and RNA sample preparation market expanded at a CAGR of 5% and reach a size of US$ 1.7 Bn at the end of 2021. The market is estimated to progress further at a CAGR of 5.6% to reach a valuation of around US$ 3.1 Bn by the end of 2032.

Persistence Market Research has assessed that DNA and RNA sample preparation kits accounted for a market value of US$ 996.3 Mn in 2021. Overall, DNA and RNA sample preparation product sales accounted for 23.4% share of the global sample preparation market in 2021.

DNA and RNA sampling is followed in different settings such as hospitals, academic institutes, forensic science laboratories, and contract research organizations (CROs) for analysis. The primary step contains sampling, which is required in clinical testing, research, and diagnosis. DNA and RNA sampling involves multiple pieces of equipment, which creates workstations, kits for systematic sample processing, and reagents for creating a standard operating environment for enzyme regulation.

DNA and RNA samples can be of various types such as blood, tissue, semen, saliva, urine, and others that can be derived from environmental samples, biosamples, or others. The growing demand for testing and analysis in different fields of life sciences such as microbiology, biochemistry, and others, with the requirement of higher throughput, increases the demand for DNA and RNA products and instruments globally.

Kits are required in large quantities in research institutes to address the challenges they go through while experimenting. An experiment has a higher chance of failure due to methodology errors. Many life science institutes are increasing their capacity to train new professionals and providing students with internships and training programs, which are often funded by the government.

Forensic scientists and professionals have faced many challenges over the past decade that are getting resolved by technological advancements. The quantity of samples, for example, bloodstains from crime scenes received is generally very less and cannot be quantified when brought back to the laboratories.

Recent developments and the introduction of easier and more efficient quantification equipment such as PCR machines have aided with sample preparation. Some laboratories have started adopting direct polymerase chain reaction (PCR) methods and microfluidic chip-based rapid DNA isolation with automation.

Attributes Key Insights

DNA and RNA Sample Preparation Market Size (2022)

US$ 1.8 Bn

Projected Market Value (2032)

US$ 3.1 Bn

Global Market Growth Rate (2022-2032)

5.6% CAGR

Market Share of Top 5 Countries

55.2%

Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

What Path Should DNA and RNA Sample Preparation Product Manufacturers Take?

“Increased Throughput and Speed of Nucleic Acid Preparations”

Smaller sample sizes, more complex sample types, and rapid nucleic acid preparation are all aspects of DNA-RNA sample preparation. Steps in sample preparation can be automated to increase production. Multi-well plate systems, such as the illustraTM RNAspin 96 RNA Isolation Kit from GE Healthcare, which consists of a multi-plate, can be utilized in conjunction with novel vacuum purification and single-use centrifuge techniques that are intended to enhance sample workflow and extraction timeframes.

InnoGenomics Technologies, which focuses on innovative genetic testing solutions, resolved problems faced by forensic experts with the help of its patented product, which addresses a range of multiplexing issues with REs (retrotransposable elements), providing high PCR efficiency as well as outstanding sensitivity, repeatability, and durability. The company also introduced the InnoGenomics’ InnoXtract system, a new method for the extraction of DNA from bone samples.

With the help of the above-mentioned factors, manufacturers of DNA and RNA sample preparation products will see lucrative growth opportunities over the coming years.

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

What’s Challenging DNA and RNA Sample Preparation Market Expansion?

“Challenges in Methodology and Sample Handling”

Sampling is an intensive method and requires skilled and dedicated personnel. Sampling involves a step-by-step process that needs to be followed rigorously due to the involvement of protein and RNA, which are sensitive and need conceptual and theoretical knowledge. Any error in a step can lead to repetition, leading to a waste of time and effort.

Increasing number of companies operating in the sample preparation market, along with added product specifications and varying value propositions, makes it difficult for clients to conclude which offer best matches their requirements. Along with the price, companies also make alterations in steps and methodology that become difficult for a person with less theoretical knowledge and also those who are new learners. This could potentially affect the overall growth of the DNA-RNA sample preparation market.

dna-and-rna-sample-preparation-market

Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Country-Wise Insights

What’s Benefitting the U.S. DNA and RNA Sample Preparation Market?

“Rise of Life Sciences Start-ups”

The U.S. accounted for 29.1% market share of the global DNA and RNA sample preparation market in 2021.

The U.S life science industry is in the era of start-ups that focus on particular segments such as clinical diagnostics, immunotherapy, drug discovery, gene therapy, and others. These start-ups are specific and work on unmet medical needs.

Due to the problems of addressing capacity and solving issues, the U.S. is leading in producing the most number of life science patents worldwide. The FDA has adopted policies that provide support for access to innovation and novel therapy development.

Thus, the U.S. market for DNA and RNA sample preparations is booming due to the increase in start-ups and research capacity.

What Makes China an Emerging Market for DNA and RNA Sample Preparation?

“Regional Expansion to Strengthen Presence”

China held the largest market share of 41.1% of the East Asia DNA and RNA sample preparation market in 2021, holding a market value of US$ 115.1 Mn.

The low-cost manufacturing sector has so far been successful in accelerating China's economic growth. To solidify its current position in the manufacturing industry, particularly in the biopharmaceutical industry, China is evaluating its presence in the regional sector.

China specifically elaborates on supply and value chains when manufactured goods are produced in another market, which is a concept that allows a central hub to continue serving as a hub for regional marketplaces. Therefore, the expansion of local and regional markets is boosting the development of DNA and RNA sample preparations in China.

What is the Stance of the Market in Germany?

“Strengthening Life Sciences Sector in Germany”

Germany held 28.6% share of the European DNA and RNA sample preparation market in 2021.

For decades, foreign businesses have been drawn to Germany's extensive network of internationally renowned universities and research institutions. Berlin, according to Germany Trade & Invest in 2021, has a significant concentration of entrepreneurial ventures, start-ups, academic facilities, and research centers with a focus on life sciences. Greater Berlin is residence to 30 pharmaceutical companies and approximately 240 biotech companies.

Germany is the European nation that submits the most biotech patent applications to the European Patent Office. Germany quickly developed into one of the world's top hubs for vaccine development in the early 2020s, in terms of both creating new vaccines and mass-producing those that already exist. More biotechnology-related EPO patent applications are filed in Germany than in any other nation in Europe.

These developmental factors make Germany a lucrative market for DNA and RNA sample preparation product suppliers.

Sales Team

Sales Team
Client Partner

Let's Connect

Connect me to identify winning opportunities

Ask An Expert
I'm Available

Category-Wise Insights

Which DNA and RNA Sample Preparation Product is Most Prominent?

“High Demand for DNA and RNA Sampling”

The kits segment held 59.2% share of the overall product segment within the global DNA and RNA sample preparation market in 2021.

Increasing demand for DNA and RNA sampling with a rise in R&D activities, diagnosis, and testing are attributed to the growth of the kits segment. Kits are used in isolation and quantification, which are primary steps; hence, usage is also high as compared to others. These kits come with a set number of tests that can be performed, which increases their adoption rate.

Which Application Drives Most Demand DNA and RNA Sample Preparation?

“Booming Research Applications in Life Sciences”

The research applications segment held 38% share of the global DNA and RNA sample preparation market in 2021.

The most use of DNA and RNA sample preparation is done in research applications as a primary step in the analysis of any life science experiment. Thus, it is contributing substantially to the DNA and RNA sample preparation market.

Research is an integral part of any industry, which provides validation and confirmation related to discoveries and innovations. High research activities in the life science sector make this segment lucrative in terms of growth.

Competitive Landscape

Leading manufacturers of DNA and RNA sample preparation products have been constantly working to develop new product lines to strengthen their existing product portfolios, meanwhile expanding their consumer base around the globe. Similarly, several major competitors in the DNA and RNA sample preparation industry have engaged in activities such as mergers and acquisitions. Moreover, manufacturing companies are receiving certifications for new products to be launched.

  • In August 2022, Roche announced the release of its first digital polymerase chain reaction (PCR) system, the Digital LightCycler System. In addition to correctly quantifying minuscule amounts of particular DNA and RNA targets that are generally undetectable by conventional PCR techniques, this next-generation device is intended to identify various diseases.
  • In August 2020, Bio-Rad Laboratories, Inc. announced that it had acquired Celsee, Inc., a company that offers instruments and consumables for the isolation, detection, and analysis of single cells.

DNA and RNA Sample Preparation Industry Report Scope

Attribute Details

Forecast Period

2022-2032

Historical Data Available for

2012-2021

Market Analysis

USD Million for Value

Key Countries Covered

  • U.S.
  • Canada
  • Brazil
  • Argentina
  • Mexico
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Russia
  • BENELUX
  • India
  • Thailand
  • Malaysia
  • Indonesia
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Turkey
  • GCC Countries
  • South Africa

Key Market Segments Covered

  • Product
  • Application
  • End User
  • Region

Key Companies Profiled

  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche
  • Illumina, Inc.
  • PerkinElmer, Inc.
  • QIAGEN
  • Merck Millipore
  • Tecan Group AG.
  • Thermo Fisher Scientific, Inc.

Report Coverage

  • Market Forecast
  • Competition Intelligence
  • DROT Analysis
  • Market Dynamics and Challenges
  • Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Segmentation of DNA and RNA Sample Preparation Industry Research

By Product:

  • Workstations
  • Kits
    • DNA Sample Preparation
    • RNA Sample Preparation
  • Reagents and Consumables

By Application:

  • Clinical Testing
  • Diagnostic Testing
  • Research Applications

By End User:

  • Hospitals
  • Diagnostic Centers
  • Academic & Research Institutes
  • Forensic Science Laboratories
  • Contract Research Organizations (CROs)

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

- Companies Covered in This Report -

  • Agilent Technologies, Inc.
  • Thermo Fisher Scientific, Inc
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • DiaSorin S.p.A
  • F. Hoffmann-La Roche
  • Illumina, Inc.
  • PerkinElmer, Inc.
  • QIAGEN
  • Merck Millipore
  • Tecan Group AG

- Frequently Asked Questions -

The global DNA and RNA sample preparation market reached a size of US$ 1.7 Bn in 2021.

Sales of the DNA and RNA sample preparation products are set to witness a CAGR of 5.6% and reach US$ 3.1 Mn by 2032.

Demand for DNA and RNA sample preparation solutions increased at 5% CAGR from 2012 to 2021.

The U.S., China, Japan, Germany, and India account for the most demand for DNA and RNA sample preparation, holding a market share of 55.2%.

The U.S. accounts for 29.1% share of the global DNA and RNA sample preparation market.

Becton, Dickinson and Company, F. Hoffmann-La Roche, and Thermo Fisher Scientific, Inc. are leading players in this market.

China held a share of 6.8% in the global DNA and RNA sample preparation market in 2021, while Japan accounted for 6.1% share.

The DNA and RNA sample preparation market in Europe is expected to expand at a CAGR of 5.4% through 2032.

Google translate